Experimental animals

There are 6 papers on aging in Experimental animals: none in people yet, 1 in animals, 5 reviews.

Organism

6 papers study it13 findings

See all 6 papers on Experimental animals

  • Animals1

Interventions

7

Dietary restriction

uplifespan2

2 studies
  1. Dietary restriction extends lifespan in E. animals (compared with ad libitum feeding).

    “delays aging and extends lifespan in experimental animals compared with a diet of ad libitum feeding (AL) control animals”

    Reviewcompared with ad libitum feeding

    Mechanisms underlying retardation of aging by dietary energy restriction

    Pathology international

  2. Dietary restriction extends lifespan in E. animals.

    “food restriction increases mean life span.”

    Review

    Diet as a modulator of aging and longevity

    Federation proceedings

More on Dietary restriction

GLP-1 receptor agonists

downinfarct volume1downinflammation1upmotor function1

1 study
  1. GLP-1 receptor agonists decrease inflammation in E. animals (stroke and Parkinson's disease models).

    “GLP-1 agonists decreased neuroinflammatory (TNF-α, IL-1b, IL-6), oxidative (ROS, 4-HNE), and apoptotic (increased Bcl-2, decreased Bax) markers.”

    Reviewstroke and Parkinson's disease models

    GLP-1 agonist and neuroprotection in Stroke and Parkinson's disease: A systematic review

    Disease-a-month : DM

  2. GLP-1 receptor agonists improve motor function in E. animals (Parkinson's disease models).

    “there was a notable improvement in motor functions (P < 0.001)”

    ReviewParkinson's disease models

    GLP-1 agonist and neuroprotection in Stroke and Parkinson's disease: A systematic review

    Disease-a-month : DM

  3. GLP-1 receptor agonists decrease infarct volume in E. animals (middle cerebral artery occlusion stroke models) (15.4 % ± 1.3 % (liraglutide); 40 % reduction with linagliptin).

    “with a significant decrease in infarct volume, such as 15.4 % ± 1.3 % (liraglutide) and 40 % reduction with linagliptin”

    Reviewmiddle cerebral artery occlusion stroke models

    GLP-1 agonist and neuroprotection in Stroke and Parkinson's disease: A systematic review

    Disease-a-month : DM

More on GLP-1 receptor agonists

Rikavit

downage-related changes in metabolic indices1upaverage and maximal lifespan1upresistance to hazardous effects and adaptive potentials1

1 study
  1. Rikavit improves resistance to hazardous effects and adaptive potentials in E. animals (hypoxia, physical and medicamentous loads).

    “increase the resistance of an aging organism to the hazardous effects (hypoxia, physical and medicamentous loads) and its adaptive potentials.”

    Animalshypoxia, physical and medicamentous loads

    Effectiveness of geriatric preparations containing natural metabolites in studies on animals of different age

    Vestnik Akademii meditsinskikh nauk SSSR

  2. Rikavit decreases age-related changes in metabolic indices in E. animals.

    “normalization of the age-related changes in metabolic indices in experimental animals.”

    Animals

    Effectiveness of geriatric preparations containing natural metabolites in studies on animals of different age

    Vestnik Akademii meditsinskikh nauk SSSR

  3. Rikavit extends average and maximal lifespan in E. animals.

    “Experimental trials have shown that this drug causes prolongation of the average and maximal life-span”

    Animals

    Effectiveness of geriatric preparations containing natural metabolites in studies on animals of different age

    Vestnik Akademii meditsinskikh nauk SSSR

More on Rikavit

Senotherapy

downcancer1uplifespan1

1 study
  1. Senotherapy lowers the risk of cancer in E. animals.

    “Senotherapy prolongs the life span and decreases the incidence of cancer in experimental animal models”

    Review

    Senotherapy, cancer, and aging

    Journal of geriatric oncology

  2. Senotherapy extends lifespan in E. animals.

    “Senotherapy prolongs the life span and decreases the incidence of cancer in experimental animal models”

    Review

    Senotherapy, cancer, and aging

    Journal of geriatric oncology

More on Senotherapy

Androgens

downmetabolic functioning1

1 study
  1. Androgens impair metabolic functioning in E. animals (androgen excess).

    “In women and experimental animals of reproductive age, androgen excess can adversely affect metabolic functioning, appetite, and body weight regulation.”

    Reviewandrogen excessfemales

    Age-Dependent Changes in the Effects of Androgens on Female Metabolic and Body Weight Regulation Systems in Humans and Laboratory Animals

    International journal of molecular sciences

More on Androgens

Fisetin

downcellular senescence1

1 study
  1. Fisetin decreases cellular senescence in aged experimental animals.

    “Senolytic agents, such as Fisetin, selectively eliminate SnCs and delay, prevent, or alleviate multiple disorders in aged experimental animals”

    Reviewin aged experimental animals

    Fisetin for COVID-19 in skilled nursing facilities: Senolytic trials in the COVID era

    Journal of the American Geriatrics Society

More on Fisetin

Melatonin

downneurodegenerative disease1

1 study
  1. Melatonin decreases neurodegenerative disease in E. animals (chemically-induced).

    “deferring the signs of chemically-induced neurodegenerative conditions in experimental animals, the data are remarkably strong”

    Reviewchemically-induced

    Melatonin, longevity and health in the aged: an assessment

    Free radical research

More on Melatonin

Latest

Dec 2025: 0Jan 2026: 0Feb 2026: 0Mar 2026: 0Apr 2026: 0May 2026: 0Jun 2026: 1Jul 2026: 0Aug 2026: 0Sep 2026: 0Oct 2026: 0Nov 2026: 01 paper in 12 months